Business
VAXXA: Q2 2024 saw doubled revenue, positive earnings, and strong cash flow, with expansion ahead
VAXXA: Q2 2024 saw doubled revenue, positive earnings, and strong cash flow, with expansion ahead
About this update from Vaxxa Ab
Vaxxa delivered strong Q2 2024 results with doubled revenue, positive EBITDA, and net income, supported by robust growth in its self-service auction platform and a solid cash position. Major platform upgrades and geographic expansion are planned for H2 2024.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.